Clinical Trial Update: Beta-carotene and Alpha-tocopherol Chemoprevention of Second Primary Malignancies in Head and Neck Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating beta-carotene and alpha-tocopherol for chemoprevention of second primary malignancies in head and neck cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Alpha-tocopherol (alpha-tocopherol)
• Beta-carotene (beta-carotene)

Snippet

Sponsor: Laval University | Conditions: Neoplasms | Phase 3 | Status: COMPLETED